Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.69%
0%
-20.69%
6 Months
-36.11%
0%
-36.11%
1 Year
53.33%
0%
53.33%
2 Years
-80.83%
0%
-80.83%
3 Years
-89.3%
0%
-89.3%
4 Years
-89.78%
0%
-89.78%
5 Years
-89.55%
0%
-89.55%
Ovoca Bio Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
9.13%
EBIT to Interest (avg)
-2.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.31
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
14.35%
Valuation key factors
Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.54
EV to EBIT
1.46
EV to EBITDA
1.46
EV to Capital Employed
1.46
EV to Sales
NA
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
100.12%
ROE (Latest)
15.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2021
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-4.20
-4.90
14.29%
Interest
0.00
0.00
Exceptional Items
0.00
-0.30
100.00%
Consolidate Net Profit
-4.80
-4.50
-6.67%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -6.67% vs -114.29% in Dec 2021
About Ovoca Bio Plc 
Ovoca Bio Plc
Pharmaceuticals: Major
Ovoca Bio plc (Ovoca) is an Ireland-based biopharmaceutical company. The Company is focused on identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD).
Company Coordinates 
Company Details
Dublin 2, 17 Pembroke Street Upper , DUBLIN None : D02 AT22
Registrar Details






